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Abstract
Autosomal recessive renal tubular dysgenesis (RTD) is a rare lethal disease affecting renal development before birth. RTD is
manifested by anuria and severe hypotension resulting in oligohydramnios and birth defects known as Potter’s syndrome.
Homozygous or compoundheterozygousmutations in genes encoding components of the renin–angiotensin system (ACE,AGT,
AGTR1 and REN) have been reported to cause RTD. A consanguineous family with a history of multiple stillbirths was
investigatedusing prenatal ultrasoundandmolecular genetic analysis of an affected foetus. Prenatal ultrasoundscan suggested
RTD, and a novel homozygous frameshift mutation c.299_300delAA (p.Lys100Serfs*4) in the REN genewas identified by whole-
exome sequencing, which segregated with parental DNA samples. RTD remains a rare but important cause of prenatal and
perinatal death and may present with antenatally hyperechogenic kidneys.
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Background
Autosomal recessive renal tubular dysgenesis (RTD) is a rare le-
thal disease affecting renal tubular development before birth
[1]. Absent or low numbers of differentiated proximal tubules is
a histological feature of this renal disease, leading to an appear-
ance of closely packed glomeruli [2].
RTD is manifested by anuria, hypotension and oligohydram-
nios, which leads to Potter’s syndrome [3]. Although autosomal
recessive RTD has been reported in some centres [4], it remains
a rare disease and the prevalence is still unknown. Mutations
in genes encoding proteins involved in the renin–angiotensin
system (RAS) are responsible [1, 5]. The RAS consists of several
proteins that are involved in a series of steps to produce angioten-
sin II protein, which regulates blood pressure and the balance of
electrolytes in the body. Mutations in the RAS genes ACE, AGT,
AGTR1 and REN have all been reported to impair the production
or function of angiotensin II, leading to RTD [2]. In a study of 48
cases, mutations inACE accounted for 64.4% of cases of RTD. Mu-
tations in REN, AGT and AGTR1were seen in 20.8, 8.3 and 6.3% of
cases, respectively [2].
REN encodes renin, which is produced by juxtaglomerular
cells in the kidney. Circulating renin hydrolyses angiotensinogen
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into the peptide angiotensin I. A further cleavage step of angio-
tensin I by endothelial-bound angiotensin-converting enzyme
in the lungs produces the vasoactive peptide angiotensin II.
REN is located on chromosome 1q32, and biallelic mutations
may cause RTD, whilst heterozygous parents of REN-related
RTD patients are typically asymptomatic [2]. Specific heterozy-
gous mutations, involving the signal peptide of renin, cause
REN-related kidney disease, a progressive form of kidney failure
associated with anaemia, hypotension and hyperuricaemia [6],
which is part of a group of conditions recently classified as auto-
somal dominant tubulointerstial kidney disease (ADTKD) [7].
In this study, we present the clinical andmolecular investiga-
tions of a family with RTD.
Case report
A first-degree consanguineous couplewho had unfortunately had
three previous prenatal deaths was referred to the Obstetric High-
Risk Clinic at King Faisal Specialist Hospital and Research Center.
Previous foetuses had ultrasound scan (USS) features of RTD, with
hyperechogenic kidneys and signs of Potter’s syndrome. In the
first affected pregnancy in 2005, the foetus had USS evidence of
anhydramnios and bilateral echogenic kidneys. The mother had
a spontaneous preterm delivery at 35 weeks gestation, and the
baby died immediately after birth. A year later, she conceived a
second pregnancy, where the foetus was diagnosed at 26 weeks
gestation, with USS evidence of anhydramnios and bilateral echo-
genic kidneys. After a spontaneous preterm delivery at 35 weeks,
the baby died immediately after delivery. In her third pregnancy
in 2008, the foetus was diagnosed following antenatal USS with
anhydramnios and bilateral echogenic kidneys at 23 weeks gesta-
tional age. Following a spontaneous preterm delivery at 34 weeks,
the baby died immediately after delivery.
During the fourth andmost recent pregnancy, themotherwas
assessed at our clinic in early pregnancy. The initial 13 weeks
antenatal USS showed normal nuchal translucency in the foetus.
Further USS imagingwas performed at 16 and 19weeks gestation.
Here, it was noticed that there was a degree of oligohydramnios,
but the foetal kidneys appeared normal. However, at 23 weeks
gestation, antenatal USS confirmed that both foetal kidneys ap-
peared hyperechogenic and bulky.
Further USS imaging of the kidneys at 26 weeks gestation re-
vealed a left kidney 50.2 mm in length and a right kidney 42.5 mm
in length. These values are above the 95th percentile for gestational
age. The USS also revealed anhydramnios and a narrow thorax.
Antenatal USS findings are summarized in Table 1 and
Figure 1.
The pregnancy continued with no additional complications,
and the mother had a spontaneous labour and delivery at
34 weeks gestation. The delivered baby had an early neonatal
death within minutes of birth. Unfortunately, we had no speci-
mens from the child for histological analysis.
The family wished to help determine the molecular cause of
the disease. Informed consent was obtained from the family and
approved by the Research Advisory Council at King Faisal Special-
ist Hospital and Research Centre. Blood samples from the affected
child and both parents’whole bloodwere obtained for genetics in-
vestigations. DNAwas extracted using the Gentra Systems PURE-
GENE DNA Isolation kit (Qiagen, USA). Molecular karyotyping
(Affymetrix CytoScan®HDArrayKit) wasperformed on the family
to exclude chromosomal aneuploidy and to determine regions of
genetics homozygosity in the foetus. No chromosomal abnormal-
ities were detected. Whole-exome sequencing (WES) using foetal
DNAwas performed in combinationwith homozygositymapping.
This identified a region of 54.7 Mb of homozygosity on chromo-
some 1 that included a novel homozygous mutation in REN
(c.299_300delAA; p.Lys100Serfs*4) (Figure 1D). Both parents were
heterozygous for the REN variant (Figure 1D). In silico analysis of
the novel variant suggested that this was a pathogenic change
(MutationTaster: disease causing) that was absent from the
Exome Aggregation Consortium database. The mutation is pre-
dicted to lead to a truncated protein or nonsense-mediated
decay of the mRNA. It is likely, although not proven, given the
lack of DNA samples, that previous miscarriages in this family
were due to a homozygous RENmutation in the affected foetuses.
Discussion
A combination of antenatal USS andmolecular investigations is a
powerful approach to characterize lethal and rare renal diseases.
RTD is a challenging disease to diagnose prenatally by ultra-
sound, and usually the diagnosis is only established at autopsy.
In RTD, the affected kidneys are usually normal in size, but
some reports suggest that they may be enlarged [8].
It is well known that the differential diagnosis of antenatal
enlarged hyperechogenic kidneys is diverse. Antenatal USS
should assess renal architecture, renal size, associated abnor-
malities and amniotic fluid volume. Inherited diseases that
cause hyperechogenic foetal kidneys include autosomal domin-
ant and autosomal recessive polycystic kidney diseases, cystic
dysplasia, Trisomy 13 and 18, Meckel–Gruber syndrome, Bar-
det–Biedl syndrome [9] and other ciliopathies. Mutations in
TCF2 encoding hepatocyte nuclear factor 1-beta is amore recent-
ly recognized important cause of antenatal hyperechogenic kid-
neys [10]. In our case, the kidneys’ size remained within normal
limits until 22 weeks gestation. It was not until 26 weeks gesta-
tion that enlarged hyperechogenic kidneys were observed,
which is a typical age at which to diagnose hyperechogenic kid-
neys due to the timing of systematic USS examinations per-
formed in the second and third trimesters. Second-trimester
Table 1. Antenatal ultrasound findings in foetus with suspected RTD
Gestation
(weeks) Amniotic fluid Kidneys Lungs Brain Heart Liver Limbs Facial features Other features
13 Normal Normal Normal Normal N/A N/A Normal Normal Nuchal translucency
normal
16 Normal Normal Normal Normal N/A Normal Normal Normal
19 Oligohydramnios Normal Normal Dolichocephaly Normal Normal Normal Normal
22 Oligohydramnios Normal Normal Dolichocephaly Normal Normal Normal Normal Small bladder
26 Anhydramnios Enlarged Small Dolichocephaly Normal Normal Normal Normal
N/A, not available.
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oligohydramnios had a poor prognosis in the cases we describe.
Third-trimester USS revealed enlarged kidneys and a narrow
thorax.
RTD is characterized histologically by an absence of proximal
tubular differentiation [11]. Prenatal death and lack of autopsy
diagnosis may explain scarce reports in the Arab world. Accord-
ing to the Centre for Arab Genomics Studies database (http://
www.cags.org.ae/), there are only two reports of familial RTD,
one from Palestine [12] and the other from Qatar [13]. Mole-
cular genetic diagnosis has become more accessible with the
advent of next-generation sequencing. WES allowed the iden-
tification of the causative gene in the family presented. The
frameshift mutation c.299_300delAA identified in REN is pre-
dicted to cause a truncated protein and may cause nonsense-
mediated mRNA decay. A variety of compound heterozygous
and homozygous mutations have been reported to cause RTD
(Figure 1E).
In conclusion, by using prenatal USS imaging andWES,we de-
scribe a novel homozygous RENmutation as the underlying mo-
lecular genetic cause of recurrent prenatal death associated with
RTD in a consanguineous Saudi Arabian family.
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Fig. 1. Prenatal ultrasound images of affected foetus and exon map of REN mutations. (A) Thirteen weeks gestation foetus (sagittal view) with a normal nuchal
translucency (measuring 1.1 mm). (B) Twenty-two weeks gestation foetus (transverse view) with head showing abnormal shape (dolichocephaly). (C) Twenty-six
weeks gestation foetus (coronal view of the abdomen) showing bilateral enlarged, hyperechogenic kidneys. (D) Sequence chromatograms of affected foetus (index
case) with one parent and a wild-type control. Foetus has a homozygous small deletion in REN (c.299_300delAA; p.Lys100Serfs*4) which is present heterozygously in
parental DNA. (E) Exon map of REN and position of known and novel mutations. REN gene and exons 1–10 are shown in schematic form. Mutations associated with
RTD are shown in black, whilst mutations associated with REN-related renal disease (which exclusively affect the peptide signal sequence encoded by exon 1) are
shown in green. The novel mutation associated with this study is highlighted in yellow.
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